| GOING FOR THE GOLD |
- ABSTRACT SUBMISSION NOW CLOSED! - The Scientific Committee would like to thank everyone who submitted an abstract to the TTS 2010 Congress. We have reached a record submission with more than 2,350 abstracts submitted. |
- LATE BREAKING ABSTRACT SUBMISSION - For all those who missed this great opportunity to submit an abstract before the regular submission deadline, please be advised that the Late Breaking Abstract Submission will open at the beginning of April. Deadline to submit late breaking abstracts is Friday, 11 June 2010. Please note there will be a $100 CAD submission fee for late breaking abstracts. |
Important Dates for Abstract Submission
Abstract Submission Deadline |
CLOSED |
Author Notification of Acceptance |
16 April 2010 |
Late Breaking Abstract Submission Deadline (fees apply) |
11 June 2010 |
Submission Guidelines
- All abstracts must be submitted electronically through the Congress Website
- Abstracts should not exceed 500 words in length.
- Tables may be included and each will count as 75 words.
- Graphics/photos are permitted and each will count as 75 words.
- Abstracts will be accepted in English only.
- There is no fee for submitting an abstract (except for late breaking abstracts).
- There is no limit to the number of abstracts you may submit.
- An international panel of reviewers will review all submitted abstracts anonymously.
- Financial disclosure information must be submitted for each co-author however, it can be submitted by the submitting author.
Submission Categories
Main Topic |
Sub-Topic |
1. Immunobiology
|
a. Bioartifical Organs and Tissue Engineering b. Experimental Immunobiology c. Experimental Immunosuppression d. Genetics and Genomics e. Tolerance – Clinical & Experimental |
2. Laboratory Immunology |
a. Histocompatibility & Immunogenetics b. Immune Monitoring and Molecular Diagnosis |
3. Donation and Allocation |
a. Donation, Allocation and Ethics b. Organ Preservation and Procurement |
4. Surgery & Imaging |
a. Advances b. Imaging |
5. Immunosuppression
|
a. Clinical Immunosuppression – Kidney Early b. Clinical Immunosuppression – Kidney Late c. Clinical Immunosuppression – Liver d. Clinical Immunosuppression – Heart & Lung e. Clinical Immunosuppression – New Agents f. Immunosuppression – Pre-Clinical Agents g. Desensitization |
6. Complications
|
a. Infections b. Cardiovascular c. Skeletal d. Metabolic e. Malignancy |
7. Xenotransplantation |
|
8. Epidemiology
|
a. Clinical Outcomes b. Registry Analysis c. Epidemiological Methods |
9. Societal
|
a. Quality of Life b. Economics c. Public Policy d. Access to Treatment e. Ethics |
10. Heart |
|
11. Lung |
|
12. Liver
|
a. Donor Allocations b. Hepatocellular Cancer c. Liver Donation d. Outcomes e. Viral Hepatitis |
13. Kidney
|
a. Acute Graft Injury b. Chronic Graft Injury c. ABO Mismatch d. Sensitized Patients e. Pathology |
14. Pancreas & Islets |
a. Pancreas b. Islets |
15. Intestine |
a. Clinical Intestine b. Multivisceral |
16. Bone Marrow Transplantation |
|
17. Tissue and Cornea |
a. Cornea b. Composite |
18. Stem Cell and Regenerative Medicine |
a. Stem Cells b. Cell Transplantation c. Tissue Regeneration |
| Presenting Authors of Accepted Abstracts are required to register for the Congress and are responsible for their own travel arrangements. Please take advantage of the Early Registration Fee by submitting your registration by 15 May 2010. All presenting authors must be registered by 16 July 2010. |
| The Organizing Committee of the TTS 2010 Congress is pleased to offer Scholarships. Please see the Scholarship page on this website for further information including application guidelines. |
| For any questions regarding your Abstract Submission please contact tts2010-speakers@meet-ics.com. |
Please continue to visit the website for the most up to date information and
Join the Mailing List to receive important announcements regarding the Congress.